The Quintiles Transitional Holdings Inc. (Q) Upgraded at Zacks Investment Research

The Quintiles Transitional Holdings Inc. (Q) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Quintiles Transitional Holdings Inc. (NYSE:Q) from a hold rating to a buy rating in a research note published on Tuesday. Zacks Investment Research currently has $89.00 price target on the stock.

According to Zacks, “Quintiles Transnational Holdings Inc. provides professional services, information and partnering solutions to the pharmaceutical services, biotechnology and healthcare industries. The Company has two segments: Product Development and Integrated Healthcare Services. It offers project management, clinical monitoring services, strategic planning and design services, consulting services contract sales, market entry/market exit, integrated channel management, patient engagement, market access and commercialization consulting, brand and scientific communication, and medical education services; outcome/observational services. The Company operates in Americas, Europe and Africa, and the Asia-Pacific. Quintiles Transnational Holdings Inc. is based in Durham, North Carolina. “

Several other research firms have also recently weighed in on Q. Goldman Sachs Group Inc. raised shares of Quintiles Transitional Holdings from a not rated rating to a buy rating and set a $94.00 price target for the company in a research note on Wednesday, October 5th. Argus reissued a buy rating and issued a $85.00 price target (up previously from $75.00) on shares of Quintiles Transitional Holdings in a research note on Thursday, August 18th. Pacific Crest increased their price target on shares of Quintiles Transitional Holdings from $75.00 to $82.00 and gave the company an overweight rating in a research note on Thursday, July 28th. Deutsche Bank AG upped their price objective on shares of Quintiles Transitional Holdings from $71.00 to $81.00 and gave the stock a buy rating in a report on Thursday, July 28th. Finally, Citigroup Inc. upped their price objective on shares of Quintiles Transitional Holdings from $72.00 to $75.00 and gave the stock a neutral rating in a report on Thursday, July 28th. Five research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company currently has a consensus rating of Buy and an average target price of $81.85.

Quintiles Transitional Holdings (NYSE:Q) opened at 75.70 on Tuesday. Quintiles Transitional Holdings has a one year low of $55.01 and a one year high of $81.45. The stock has a market capitalization of $8.97 billion, a price-to-earnings ratio of 22.76 and a beta of 0.58. The company’s 50-day moving average is $78.02 and its 200 day moving average is $71.64.

Quintiles Transitional Holdings (NYSE:Q) last announced its quarterly earnings data on Wednesday, July 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.03. Quintiles Transitional Holdings had a net margin of 6.83% and a negative return on equity of 189.34%. The company earned $1.17 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the prior year, the company earned $0.78 EPS. Quintiles Transitional Holdings’s revenue was up 8.6% compared to the same quarter last year. Equities analysts expect that Quintiles Transitional Holdings will post $3.82 EPS for the current year.

Large investors have recently made changes to their positions in the stock. Pacer Advisors Inc. raised its stake in shares of Quintiles Transitional Holdings by 22.2% in the second quarter. Pacer Advisors Inc. now owns 1,685 shares of the company’s stock worth $110,000 after buying an additional 306 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in shares of Quintiles Transitional Holdings by 41.7% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 1,700 shares of the company’s stock worth $111,000 after buying an additional 500 shares during the last quarter. Invictus RG purchased a new stake in shares of Quintiles Transitional Holdings during the second quarter worth $125,000. Citizens Financial Group Inc RI raised its stake in shares of Quintiles Transitional Holdings by 1.0% in the first quarter. Citizens Financial Group Inc RI now owns 1,978 shares of the company’s stock worth $129,000 after buying an additional 20 shares during the last quarter. Finally, Acrospire Investment Management LLC purchased a new stake in shares of Quintiles Transitional Holdings during the first quarter worth $130,000. Institutional investors and hedge funds own 92.78% of the company’s stock.

Quintiles Transitional Holdings Company Profile

Quintiles Transnational Holdings Inc is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. The Company’s segments include Product Development and Integrated Healthcare Services.

Related posts

Leave a Comment